We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sensyne Health, a UK-based clinical artificial intelligence (AI) technology firm, has collaborated with German pharmaceutical company Bayer to accelerate the development of new heart therapies.
Germany-based Bayer Pharmaceuticals has partnered with Imperial College London to leverage artificial intelligence (AI) to drive drug discovery for heart disorders....